Teva Pharmaceutical Industries Lt.../ IL0062905489 /
2018-12-14 12:00:00 AM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
355.0000USD | - | 21,953 Turnover: - |
-Bid Size: - | -Ask Size: - | 362.0000 | 311.0500 |
GlobeNewswire
05-13
Alvotech Announces Webcast of First Quarter 2024 Financial Results on May 22, 2024, at 8:00 am EDT (...
GlobeNewswire
04-30
U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentratio...
GlobeNewswire
04-24
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimil...
GlobeNewswire
04-19
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable...
GlobeNewswire
04-16
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara®...
GlobeNewswire
03-20
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
GlobeNewswire
03-05
Alvotech Announces Webcast of Full Year 2023 Financial Results on March 21, 2024, at 8:00 am ET
GlobeNewswire
02-26
Alvotech Accepts Offer for the Sale of Shares for a value of approximately USD 166 million at a Purc...
GlobeNewswire
02-24
Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interc...
GlobeNewswire
02-15
Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar to Stelara® (ustekinumab)
GlobeNewswire
02-08
Acrivon Therapeutics Appoints Seasoned Industry Executive Ivana Magovčević-Liebisch, Ph.D., J.D., to...
GlobeNewswire
01-31
Orange Grove Bio Sets Sights on Rapidly Emerging Middle East Biotech Ecosystem through New Academic ...
GlobeNewswire
01-29
Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT03, a Proposed Bios...
GlobeNewswire
01-19
Alvotech Provides Update on Status of Biologics License Applications for AVT02 and AVT04
GlobeNewswire
01-10
STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara
GlobeNewswire
01-03
Alvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT...
GlobeNewswire
2023-11-29
Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT05, a Proposed Bios...
GlobeNewswire
2023-11-28
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update